Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Neuropharmacology|April 29, 1999
Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responsesC S Yuan, J F FossEuropean Journal of Pharmacology|March 24, 1995
Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestineC S Yuan, J F Foss, J MossCancer Chemotherapy and Pharmacology|September 23, 1998
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphineJ F Foss, C S Yuan, M F Roizen, et al.Journal of Clinical Pharmacology|November 24, 1998
Effects of low-dose morphine on gastric emptying in healthy volunteersC S Yuan, J F Foss, M O'Connor, et al.Journal of Clinical Pharmacology|November 10, 1998
Gut motility and transit changes in patients receiving long-term methadone maintenanceC S Yuan, J F Foss, M O'Connor, et al.Clinical Pharmacology and Therapeutics|April 1, 1997
The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit timeC S Yuan, J F Foss, J Osinski, et al.Clinical Pharmacology and Therapeutics|April 1, 1996
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trialC S Yuan, J F Foss, M O'Connor, et al.Drug and Alcohol Dependence|November 4, 1998
Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphineC S Yuan, J F Foss, M O'Connor, et al.Journal of Clinical Pharmacology|January 1, 1997
Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic studyJ F Foss, M F O'Connor, C S Yuan, et al.Pageof 11